*Disclaimer

WELLNEX LIFE LIMITED (ASX: WNX)

🔗 📄 📈

WNX: Trading Update

WELLNEX LIFE LIMITED

2023-04-12 08:55:00

WNX: Wellnex to Enter the SAS-B Medicinal Cannabis Market with CW

WELLNEX LIFE LIMITED

2023-03-14 08:49:00

WNX: Pharmacy Own Products Update

WELLNEX LIFE LIMITED

2023-02-14 08:08:00

WNX: Trading Update - Half Year Ended 31 December 2022

WELLNEX LIFE LIMITED

  1. Revenue for Half Year FY23 at $13.2 million (unaudited) compared to prior corresponding period of $8.6 million, an increase of 54%.
  2. Launch of Pharmacy Own in the first quarter of CY23 – with first products to be available by the end of January 2023.
  3. Medicinal cannabis products to be offered under the SAS-B scheme in the first quarter of CY23.

2023-01-09 08:58:00